Center Advisors, Dissemination & Implementation Core
Beth McGinty, PhD, MS
Beth McGinty, PhD, MS
Professor; Associate Chair for Research and Practice, Department of Health Policy and Management; Co-Director, Center for Mental Health and Addiction Policy; Co-Director, ALACRITY Center for Health and Longevity in Mental Illness
Dr. Beth McGinty is a health policy researcher whose work focuses on mental health and substance use. Two major research foci include study of the implementation and outcomes of policies with the potential to support integration of behavioral, somatic, and social services for people with serious mental illness and analysis of how state laws affect the drug addiction and overdose crisis in the U.S. A hallmark of Dr. McGinty’s research is her use of mixed-methods to bring together approaches from the fields of public policy and implementation science. Dr. McGinty also conducts communication research examining how communication strategies influence public stigma toward, and support for policies that benefit, people with mental health or substance use conditions. At Johns Hopkins, Dr. McGinty teaches the course Social Policy for Vulnerable Populations and serves as the Co-Director of the Johns Hopkins Center for Mental Health and Addiction Policy Research. She also Co-Directs the Johns Hopkins ALACRITY Center for Health and Longevity in Mental Illness. She completed her PhD in Health and Public Policy from the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health in 2013 and was awarded a MS in Health and Behavior Studies from Columbia University in 2006. Outside of work, Dr. McGinty can usually be found running, biking, hiking or playing cards with her family.
Selected Publications
- McGinty EE, Murphy KA, Dalcin AT, Stuart EA, Wang NY, Dickerson F, Gudzune K, Jerome G, Thompson D, Cullen BA, Gennusa J, Kilbourne AM, Daumit GL. A model for advancing scale-up of complex interventions for vulnerable populations: The ALACRITY Center for Health and Longevity in Mental Illness. J Gen Intern Med. 2021 Feb;36(2):500-505. doi: 10.1007/s11606-020-06137-x. PMID: 32869192; PMCID: PMC7878664. View Source
- McGinty EE, Tormohlen KN, Barry CL, Bicket MC, Rutkow L, Stuart EA. Protocol: Mixed-methods study of how implementation of US state medical cannabis laws affects treatment of chronic non-cancer pain and adverse opioid outcomes. Implement Sci. 2021 Jan 7;16(1):2. doi: 10.1186/s13012-020-01071-2. PMID: 33413454; PMCID: PMC7789408. View Source
- McGinty EE, Presskreischer R, Anderson KE, Han H, Barry CL. Psychological distress and COVID-19-related stressors reported in a longitudinal cohort of US adults in April and July 2020. JAMA. 2020 Dec 22;324(24):2555-2557. doi: 10.1001/jama.2020.21231. PMID: 33226420; PMCID: PMC7684524. View Source
- McGinty EE, Stone EM, Kennedy-Hendricks A, Bachhuber MA, Barry CL. Medication for opioid use disorder: A national survey of primary care physicians. Ann Intern Med. 2020 Jul 21;173(2):160-162. doi: 10.7326/M19-3975. PMID: 32311740; PMCID: PMC8171002. View Source
- McGinty EE, Barry CL. Stigma reduction to combat the addiction crisis - Developing an evidence base. N Engl J Med. 2020 Apr 2;382(14):1291-1292. doi: 10.1056/NEJMp2000227. PMID: 32242352. View Source